HOME News Release
2017
Dec 18
Launch of the Photodynamic Diagnostic Agent “ALAGLIO® Divided Granules 1.5g”- Contributing to the Initial Treatment of Non-Muscle Invasive Bladder Cancer through the Visualization of Tumor Lesions -
(41.4 KB)
Dec 7
Notice Regarding a Basic Agreement on Capital and Business Partnerships with Huobi Group, which conducts Cryptocurrency-related Businesses in the Asian Region Centered on China
(99.9 KB)
Dec 1
Notice on Result and Completion of Repurchase of the Company’s Own Shares (Repurchase of Company’s Own Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Companies Act)
(30.2 KB)
Nov 13
Notice Regarding an Agreement of Establishing a Joint Venture between SBI Holdings and Decentralized Mobile Applications Ltd. that Provides PayKey’s Channel-Agnostic Mobile Banking Service
(91.1 KB)
Oct 26
Interim Dividend for the Fiscal Year Ending March 31, 2018
(96.7 KB)
Oct 20
Notice Regarding Investment into Decentralized Mobile Applications Ltd.
(100.7 KB)
Oct 20
Notice Regarding on an Agreement of Establishing a Joint Venture between SBI Holdings and Wirex Limited that Provides Payment Services of Cryptocurrencies
(81.4 KB)
Oct 19
Interim Results Announcement for the Six Months Ended September 30, 2017 of SBI SECURITIES
(28.2 KB)
Oct 18
Notice Regarding Reports on Ripple
(61.2 KB)
Oct 11
Morningstar Japan Launches Japan's First Ever Ratings Services on Cryptocurrencies and ICOs
(53.9 KB)
Oct 6
SBI Launching Corda Training Program for Japan Market in Partnership with Enterprise Software Firm, R3
(109.1 KB)
Sep 27
“ALAGLIO® Divided Granules 1.5g,” a Photodynamic Diagnostic Agent Obtained Manufacture and Marketing Approval
(152.8 KB)
Sep 21
Notice Regarding Share Acquisition of Wealth Trust Securities in Sri Lanka
(71.6 KB)
Sep 19
Notice Regarding Business Alliance in Virtual Currency Area with CoVenture Holding Company
(90.9 KB)
Sep 14
SBI Holdings, SBI BITS and NEC Commence Joint Demonstration Trial of KYC Operations Using Blockchain Technology
(63.7 KB)
Sep 1
Determination of Details of Issuance of Stock Acquisition Rights(Paid-In Capital Stock Options and Qualified Stock Options)
(104.6 KB)
Sep 1
Mitsui Kinzoku and SBI Investment Jointly Establish Private Fund
(137.9 KB)
Aug 30
Notice on Results of Repurchase of the Company's Own Shares through ToSTNeT-3(Repurchase of Company's Own Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Companies Act)
(174 KB)
Aug 29
Notice Regarding Determination of Terms of Issue, etc. of Zero Coupon Convertible Bonds due 2020 and Zero Coupon Convertible Bonds due 20222020年満期ユーロ円建転換社債型新株予約権付社債及び2022年満期ユーロ円建転換社債型新株予約権付社債の発行条件等の決定に関するお知らせ ” uploaded on the Company’s Japanese website.
Aug 29
Notice Regarding the Issuance of Zero Coupon Convertible Bonds due 2020 and Zero Coupon Convertible Bonds due 20222020年満期ユーロ円建転換社債型新株予約権付社債及び2022年満期ユーロ円建転換社債型新株予約権付社債の発行に関するお知らせ ” uploaded on the Company’s Japanese website.
Aug 29
Notice Regarding Repurchase of the Company’s Own Shares through ToSTNeT-3 (Repurchase of Company’s Own Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Companies Act)
(80.3 KB)
Aug 29
Notice Regarding Repurchase of the Company’s Own Shares (Repurchase of Company’s Own Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Companies Act)
(75.6 KB)
Jul 28
Partial Determination of Details of Issuance of Stock Acquisition Rights(Paid-In Capital Stock Options)
(24.5 KB)
Jul 28
Quark Pharmaceuticals Reports Positive Results from a Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury (AKI) in Subjects at High Risk of AKI Following Cardiac Surgery
(58.9 KB)
Jul 27
Issuance of Stock Acquisition Rights (Paid-In Capital Stock Options and Qualified Stock Options)
(152.8 KB)
Jul 19
First Quarterly Results Announcement for the Three Months Ended June 30, 2017 of SBI SECURITIES
(48.7 KB)
Jul 18
Notice Regarding an Investment into FinLeap GmbH
(79.5 KB)
Jun 30
Notice of Launch of First Money Transfer Services between Japan and Kingdom of Thailand by Utilizing Distributed Ledger Technology
(80.6 KB)
Jun 23
FDA has Approved Intraoperative Imaging Agent for Malignant Glioma, One of Brain Tumors, Developed by photonamic
(120.6 KB)
Jun 8
Listing of Sihanoukville Autonomous Port in Cambodia with SBI Royal Securities Serving as Its Lead Manager
(151.8 KB)
May 24
Notice of Memorandum of Understanding on Establishing of a Joint Venture Leasing Company with ReNet Japan Group Co., Ltd.in Cambodia
(130.1 KB)
May 24
Notice Regarding an Investment into R3 HOLDCO LLC, a U.S. FinTech Company
(93 KB)
Apr 28
Notice regarding Adjustment of Conversion Price for \30,000,000,000 Zero Coupon Convertible Bonds Due 2017
(24 KB)
Apr 24
Positive Data of Phase III Clinical Trial in Patients of Non-Muscle Invasive Bladder Cancer were Presented at the 105th Annual Meeting of the Japanese Urological Association
(125.1 KB)
Apr 18
Annual Results Announcement for the Fiscal Year Ended March 31, 2017 of SBI SECURITIES
(40.6 KB)
Mar 31
Notice Regarding the Reorganization of Subsidiaries that Aggregate the Group’s FinTech-related Businesses and the Change of Subsidiary’s Corporate Name
(83.3 KB)
Mar 24
Operational Launch of Insurance Holding Company and Changes to Representatives of Subsidiaries
(98.7 KB)
Mar 15
Notice Regarding an Investment into solarisBank AG
(81.2 KB)
Mar 14
Revision of Dividend Forecast for the Fiscal Year Ending March 31, 2017
(80.7 KB)
Mar 13
SBI Pharma and Chugai Enter an Agreement of Exclusive Marketing Rights for “ALAGLIO® Granule 1.5g” in Japan
(51.1 KB)
Mar 9
Notice Regarding an Investment into Veem Inc.
(83.2 KB)
Mar 7
Notice Regarding an Investment into Wirex Limited through a Fund
(79.6 KB)
Mar 3
Notice Regarding an Investment into Episode Six Limited
(85.3 KB)
Mar 2
Announcing the Successful Completion of RC Cloud Pilot
By Japan Bank Consortium -- Moving into the Commercial Phase
(111.3 KB)
Feb 7
Change in Major Shareholder
(101.7 KB)
Jan 27
Notice on the Start of Phase II Clinical Trial using 5-ALA by University of Oxford and SBI Pharmaceuticals
(160.1 KB)
Jan 23
Notice Regarding the Execution of Capital and Business Alliance Agreement between Daiwa Securities Group and the SBI Group on Defined Contribution Pension Plan Business
(126.7 KB)
Jan 19
Third Quarterly Results Announcement for the Nine Months Ended December 31, 2016 of SBI SECURITIES
(66.7 KB)
Adobe Reader Adobe Reader to view these PDF files.
There is no charge for downloading Adobe Reader.
The logos of Adobe Reader and Adobe Reader are the registered trademarks of Adobe Systems.
